Identifier |
20110208_nanos_posters_118 |
Title |
Role for Low-Contrast Acuity as Part of a New MS Disability Composite Measure |
Creator |
Laura Balcer; Steven Galetta; Richard Rudick; Chris Polman; Christophe Hotermans; Annie Zhang; Robert Hyde |
Affiliation |
(LB) (SG) University of Pennsylvania, Philadelphia, PA; (RR) Cleveland Clinic Foundation, Cleveland, OH; (CP)Vrije Universiteit Medical Centre, Amsterdam, Netherlands; (CH) (AZ) (RH) Biogen Idec Inc., Weston, MA |
Subject |
Low-Contrast Acuity; Vision; Multiple Sclerosis; Disability; Natalizumab |
Description |
In the AFFIRM trial of natalizumab vs. placebo for relapsing multiple sclerosis (MS), there was a reduction in sustained loss of low-contrast acuity (LCA) for patients on natalizumab. LCA captures information on visual function not entirely captured by the Expanded Disability Status Scale (EDSS) or the MS Functional Composite (MSFC), making these measures complementary for assessing disability. |
Date |
2011-02-08 |
Language |
eng |
Format |
application/pdf |
Type |
Text |
Source |
2011 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2011: Poster Presentations |
Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
Publisher |
North American Neuro-Ophthalmology Society |
Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
Rights Management |
Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s6t470km |
Setname |
ehsl_novel_nam |
ID |
181741 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6t470km |